	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	2,758	3,423	2,977	2,579	2,324	2,500	3,034	3,357	2,735	2,317	2,868	2,651	3,294	3,768	4,211
Cost of Operating Revenue	2,169	2,782	2,583	1,848	1,900	2,030	2,477	2,648	2,216	1,836	2,380	2,143	2,643	2,970	3,218
Gross Profit	589	640	393	731	424	470	557	709	519	481	488	508	651	798	994
Gross Margin	21.3	18.7	13.2	28.3	18.2	18.8	18.4	21.1	19.0	20.7	17.0	19.2	19.8	21.2	23.6
Total Operating Expenses	2,401	3,057	2,846	2,544	2,216	2,332	2,784	2,979	2,496	2,114	2,682	2,417	2,976	3,330	3,718
Operating Profit	357	365	131	35	109	168	251	378	239	203	187	234	318	438	494
Operating Margin	12.9	10.7	4.4	1.4	4.7	6.7	8.3	11.3	8.7	8.8	6.5	8.8	9.7	11.6	11.7
Financing Income/(Expense) - Net	-237	-225	-152	-157	-132	-124	-119	-172	-128	-92	-61	-111	-116	-193	-167
Profit before Taxes	120	140	-212	-144	-81	45	148	214	113	120	348	154	207	246	331
Income Taxes	52	44	-50	-55	-24	10	51	81	38	11	39	24	50	61	84
Profit after Tax	67	96	-161	-89	-57	35	97	133	115	132	340	125	173	231	293
PAT Margin	2.4	2.8	-5.4	-3.4	-2.4	1.4	3.2	4.0	4.2	5.7	11.8	4.7	5.3	6.1	7.0
EPS - Basic - ex Extraordinary Items	12.09	16.23	-26.06	-14.32	-9.17	5.66	15.59	21.42	12.09	17.64	53.22	20.20	27.94	37.29	45.95
EPS - Diluted - ex Extraordinary Items	12.09	16.23	-26.06	-14.32	-9.17	5.66	15.59	21.42	12.09	17.64	53.22	20.20	27.94	37.29	45.95
EBIT	357	365	131	35	109	168	251	378	239	203	187	234	318	438	494
EBITDA	442	455	221	131	178	240	324	454	316	283	267	328	419	553	649
EBITDA Margin	16.0	13.3	7.4	5.1	7.7	9.6	10.7	13.5	11.6	12.2	9.3	12.4	12.7	14.7	15.4

Balance Sheet

Abridged

Understanding Balance Sheet

India Glycols Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	1,619	1,628	1,730	1,540	1,277	1,132	1,079	1,385	1,595	1,328	1,607	1,646	1,945	1,816	1,498
Long-Term Investments	2	2	4	4	45	65	25	26	23	22	82	13	7	2	43
Property Plant & Equipment - Net	105	1,383	1,414	2,184	2,210	2,201	2,245	2,302	2,390	2,309	2,552	2,832	3,280	3,924	4,588
Total Non-Current Assets	1,467	1,490	1,512	2,263	2,343	2,361	2,343	2,399	2,491	2,792	3,023	3,212	3,672	4,360	5,025
Total Assets	3,086	3,118	3,243	3,803	3,620	3,492	3,421	3,784	4,086	4,119	4,631	4,858	5,617	6,176	6,523
Total Current Liabilities	2,077	1,698	2,042	2,396	1,836	1,902	1,665	1,725	1,984	1,733	1,749	1,865	2,375	2,321	2,014
Long Term Debt	716	717	709	396	195	65	172	396	421	515	540	565	745	1,107	1,000
Total Non-Current Liabilities	837	884	828	631	1,065	838	911	1,097	1,068	1,217	1,110	1,092	1,191	1,599	1,576
Total Liabilities	2,914	2,582	2,870	3,028	2,901	2,740	2,576	2,822	3,052	2,951	2,858	2,957	3,566	3,920	3,590
Total Shareholders' Equity	414	536	372	775	718	752	845	963	1,034	1,169	1,792	1,901	2,051	2,256	2,933
Minority Interest	-	-	-	-	-	-	-	-	-	-	-19	-	-	-	-
Total Equity	414	536	372	775	718	752	845	963	1,034	1,169	1,772	1,901	2,051	2,256	2,933
Total Liabilities & Equity	3,328	3,118	3,243	3,803	3,620	3,492	3,421	3,784	4,086	4,119	4,631	4,858	5,617	6,176	6,523

Cash Flow

Abridged

Understanding Cash Flow Statement

India Glycols Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	188	191	-68	-62	-1	109	229	258	230	154	163	158	320	327	507
Working Capital - Increase/(Decrease)	-356	475	-328	-274	1,096	66	155	-253	-21	-143	-125	93	34	-113	144
Net CF from Operating Activities	-168	666	-397	-336	1,096	175	383	4	210	11	38	251	354	214	651
Capital Expenditures - Net	102	161	102	-118	94	42	129	139	155	149	380	435	542	753	817
Net CF from Investing Activities	-214	-266	95	156	-91	-48	-115	-134	-157	-149	79	-354	-542	-753	-817
Dividends Paid - Cash - Total	5	22	9	4	0	0	4	15	44	0	18	23	23	25	75
Stock - Issuance/(Retirement) - Net	-	43	-	2	-	-	-	-	-	-	-	-	-	-	467
Debt - LT & ST - Issuance/(Retirement) - Total	403	-413	273	182	-1,020	-128	-265	166	-31	137	-95	122	227	484	-226
Net Cash Flow from Financing Activities	398	-392	264	180	-1,020	-128	-269	151	-76	137	-114	98	204	459	166
Free Cash Flow to Equity	133	93	-226	-36	-19	5	-11	32	24	0	-437	-62	39	-56	-392
Free Operating CF net dividend	-287	476	-521	-411	1,001	133	250	-150	10	-138	-360	-211	-222	-571	-248
Free Operating CF	-282	498	-512	-407	1,001	133	254	-135	55	-137	-342	-188	-199	-547	-173

Business Segment Analysis

FY End:

Mar 25

India Glycols Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Assets

BioMbased Specialities and Performance Chemicals (29.9%)₹ 3,543.43 CrBioMbased Specialities and Performance Chemicals (29.9%)₹ 3,543.43 CrBio Fuel (9.4%)₹ 1,116.63 CrBio Fuel (9.4%)₹ 1,116.63 CrPotable Spirits (4.9%)₹ 579.23 CrPotable Spirits (4.9%)₹ 579.23 CrUnallocable (4.2%)₹ 495.80 CrEnnatuer Blopharma (3.7%)₹ 441.00 CrEnnatuer Blopharma (3.7%)₹ 441.00 Cr

Regional Segment Analysis

FY End:

Mar 14

India Glycols Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Domestic (66.0%)₹ 2,326.64 CrOverseas. (34.0%)₹ 1,199.90 Cr

Assets

Domestic (90.6%)₹ 2,407.93 CrOverseas. (9.4%)₹ 248.75 Cr

Historical Segment Analysis

Track how India Glycols Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Business

Regional

Business

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31

Industrial Chemicals	79	77	73	166	100	44	98	112	118	107	308
Liquor	4	0	4	3	11	-	-	-	-	-	-
Other	17	30	10	16	15	-	-	-	-	-	-
Unallocable	41	4	1	7	14	0	0	0	0	0	0
Ethyl Alcohol	-	-	-	-	-	1	0	9	18	17	27
Nutraceutical	-	-	-	-	-	11	15	19	20	28	62

Frequently Asked Questions

What is the revenue of India Glycols Ltd.?

The latest trailing twelve month revenue of India Glycols Ltd. is ₹ 4,211.41 Cr, reflecting a 1-year growth of 11.76% and a 3-year CAGR of 16.68%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of India Glycols Ltd.?

The latest trailing twelve month net profit (PAT) of India Glycols Ltd. is ₹ 292.76 Cr, with a 3-year earnings CAGR of 31.52%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of India Glycols Ltd.?

The trailing twelve month EBITDA of India Glycols Ltd. is approximately ₹ 493.87 Cr (based on an operating margin of 11.73%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of India Glycols Ltd.?

The trailing twelve month Earnings Per Share (EPS) of India Glycols Ltd. is 45.95. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of India Glycols Ltd.?

The debt-to-equity ratio of India Glycols Ltd. stands at 0.58. The interest coverage ratio is 2.95x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of India Glycols Ltd.?

The estimated book value per share of India Glycols Ltd. is 437.71 (derived from a P/B ratio of 2.46 and market price of ₹ 1,075.75), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of India Glycols Ltd.?

The trailing twelve month operating cash flow of India Glycols Ltd. is ₹ 650.90 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does India Glycols Ltd. report consolidated or standalone financials?

India Glycols Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.